Clinical trial · Observational
Role of MRI in Breast Cancer Subtypes
Role of MRI in Detection of Breast Cancer Molecular Subtypes in Correlation With Immunohistochemistry Results
NCT06707584CI-TRIAL-00083058MRInot yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
efficacy of MRI in detection of breast cancer molecular subtypes instead of biopsy and immunohistochemistry
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| MRI in Breast Cancer | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- accuracy of MRI in breast cancer subtyping
- timeFrame
- 5 years
- description
- To investigate the diagnostic accuracy of dynamic post contrast imaging MRI in evaluation of breast cancer molecular subtypes and DWI and ADC in detection of breast cancer molecular subtypes
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: a. patients with breast cancer confirmed by histopathology, Exclusion Criteria: 1. breast implants 2. general Contraindication of MRI as claustrophobia
References
Publications (0)
Data not yet available
No reference posted for this study.